Literature DB >> 16418185

Radical external beam radiotherapy for prostate cancer in Japan: results of the 1999-2001 patterns of care process survey.

Kazuhiko Ogawa1, Katsumasa Nakamura, Hiroshi Onishi, Tomonari Sasaki, Masahiko Koizumi, Yoshiyuki Shioyama, Takafumi Komiyama, Yuuki Miyabe, Teruki Teshima.   

Abstract

BACKGROUND: The Patterns of Care Study evaluated standards of practice for patients with clinically localized prostate cancer treated with radiotherapy in Japan. This study examined the influence of institutional stratification on care for patients receiving radical external beam radiotherapy.
METHODS: A national survey of 66 institutions was conducted using two-stage cluster sampling, and detailed information was accumulated on 283 patients who received radiotherapy between 1999 and 2001.
RESULTS: In A (academic) and B (non-academic) institutions, more than 80% of patients had intermediate or unfavorable risk disease. Although there were no significant differences in disease characteristics between A and B institutions, institutional stratification significantly affected radiotherapy practice patterns, such as the use of a CT-based treatment planning (A1: 91.5%, B: 77.1%; P = 0.0007) and the use of conformal therapy (A: 56.4%, B: 24.1%; P < 0.0001). CT-based treatment planning and conformal therapy significantly influenced total radiation dose (P < 0.0001 for each). Hormonal therapy was commonly used in both A and B institutions (A: 89.0%, B: 90.7%). Many patients with a favorable prognosis (A: 62.5%, B: 91.7%) received hormonal therapy, and most patients with unfavorable risk disease (A: 93.6%, B: 91.6%) also received hormonal therapy.
CONCLUSION: During the period 1999-2001, the majority of prostate cancer patients treated in Japan with radical external beam radiotherapy had advanced diseases. Institutional stratification significantly affected radiotherapy practice patterns, with the notable exception that radiotherapy was commonly combined with hormonal therapy regardless of the institutional stratification and individual risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418185     DOI: 10.1093/jjco/hyi216

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

1.  Impact of the duration of hormonal therapy following radiotherapy for localized prostate cancer.

Authors:  Mitsuru Okubo; Hidetugu Nakayama; Tomohiro Itonaga; Y U Tajima; Sachika Shiraishi; Ryuji Mikami; Akira Sakurada; Shinji Sugahara; Kiyoshi Koizumi; Koichi Tokuuye
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

2.  Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with T1c-T2N0M0 prostate cancer.

Authors:  Takashi Mizowaki; Kenji Takayama; Yoshiki Norihisa; Masakazu Ogura; Tomomi Kamba; Takahiro Inoue; Yosuke Shimizu; Toshiyuki Kamoto; Osamu Ogawa; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2011-10-05       Impact factor: 3.402

3.  External-beam radiotherapy for clinically localized prostate cancer in Osaka, Japan, 1995-2006: time trends, outcome, and risk stratification.

Authors:  Yasuo Yoshioka; Osamu Suzuki; Kana Kobayashi; Teruki Teshima; Yuji Yamada; Tadayuki Kotsuma; Masahiko Koizumi; Kazufumi Kagawa; Masashi Chatani; Shigetoshi Shimamoto; Eiichi Tanaka; Hideya Yamazaki; Takehiro Inoue
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

Review 4.  Radical external beam radiotherapy for prostate cancer in Japan: differences in the patterns of care among Japan, Germany, and the United States.

Authors:  Kazuhiko Ogawa; Katsumasa Nakamura; Tomonari Sasaki; Hiroshi Onishi; Masahiko Koizumi; Masayuki Araya; Yoshiyuki Shioyama; Atsushi Okamoto; Michihide Mitsumori; Teruki Teshima
Journal:  Radiat Med       Date:  2008-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.